- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Hematologic Malignancies in United Kingdom
Total 8398 results
-
University College, LondonMedical Research CouncilCompletedHaematological MalignanciesUnited Kingdom
-
Nottingham University Hospitals NHS TrustNewcastle University; University of Kansas; Macmillan Cancer Support; Bishop Grosseteste...TerminatedCancer | Oncologic Disorders | Nutrition Aspect of Cancer | Haematological MalignancyUnited Kingdom
-
University College, Londonbluebird bioActive, not recruitingPost-transplant Lymphoproliferative Disease | Transplant-Related Hematologic MalignancyUnited Kingdom
-
Fred Hutchinson Cancer CenterRecruitingHematopoietic and Lymphoid Cell NeoplasmUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedHematological MalignanciesUnited States
-
Dana-Farber Cancer InstituteGenentech, Inc.; BiogenCompleted
-
Washington University School of MedicineRecruitingPediatric Hematologic MalignanciesUnited States
-
Stefanie Sarantopoulos, MD, PhD.CompletedHematological MalignanciesUnited States
-
University of UtahTerminatedHigh Risk Hematologic MalignanciesUnited States
-
Vanda PharmaceuticalsUnknownRelapsed or Refractory Hematologic MalignanciesUnited States
-
The Christie NHS Foundation TrustRecruitingCOVID | Oncology | Haematological MalignancyUnited Kingdom
-
Ascentage Pharma Group Inc.RecruitingAdvanced Solid Tumors or Hematologic MalignanciesUnited States
-
M.D. Anderson Cancer CenterRoche Pharma AGCompletedHematological MalignanciesUnited States
-
West Virginia UniversityCompletedHematological Malignancy | Pharmacokinetics of AcyclovirUnited States
-
Precision BioSciences, Inc.RecruitingHematologic Malignancy | CD19 Expressing MalignanciesUnited States
-
Anand B. KarnadCompletedAdvanced B-cell Lymphoid MalignanciesUnited States
-
Clavis PharmaCompletedAML | Hematologic MalignanciesUnited States, United Kingdom, France, Germany, Italy, Norway
-
University of Illinois at ChicagoRecruitingRelapsed or Refractory Hematologic MalignanciesUnited States
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Solid Malignancies | Hematologic MalignanciesUnited States
-
CelgeneCompletedHematologic Malignancy | Malignant LymphomaUnited States, United Kingdom
-
St. Jude Children's Research HospitalCompleted
-
CelgeneCompletedHematologic Malignancy | Malignant LymphomaUnited States, United Kingdom
-
Effector TherapeuticsTerminated
-
Imperial College LondonUniversity of Nottingham; Nottingham University Hospitals NHS Trust; NHS Blood... and other collaboratorsCompletedAutoimmune Diseases | Haematological Malignancies | Solid Organ Transplant RecipientsUnited Kingdom
-
Emory UniversityTerminatedThrombocytopenia | Hematological MalignanciesUnited States
-
HutchmedRecruitingIsocitrate Dehydrogenase Gene MutationSpain, United States
-
University of Michigan Rogel Cancer CenterOtsuka Pharmaceutical Development & Commercialization, Inc.Completed
-
University of ChicagoCompletedLeukemia | Preleukemia | Advanced Hematologic MalignanciesUnited States
-
Spectrum Health HospitalsMillennium Pharmaceuticals, Inc.CompletedHematological MalignancyUnited States
-
Anthony Sung, MDMassachusetts General HospitalCompleted
-
M.D. Anderson Cancer CenterImmunoGen, Inc.Completed
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...CompletedHematologic MalignancyUnited States
-
Baptist Health South FloridaWithdrawnNon-Hodgkin Lymphoma | Hematologic Malignancy | B-Cell Lymphoid MalignanciesUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Novartis... and other collaboratorsTerminated
-
IncuronTerminatedHematological MalignanciesUnited States
-
Gemin XCompletedHematological MalignanciesUnited States, Canada
-
AstraZenecaQuintiles, Inc.CompletedSolid MalignanciesUnited Kingdom
-
Aaron Cumpston, PharmD, BCOPCompletedNeutropenia | Hematological MalignancyUnited States
-
Karyopharm Therapeutics IncCompletedHematological MalignanciesUnited States, Denmark, Canada
-
University College, LondonSuspendedCMV Infection | Haematological MalignanciesUnited Kingdom
-
M.D. Anderson Cancer CenterICN PharmaceuticalsCompletedHematological MalignanciesUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteCancer and Aging Research GroupRecruitingLymphoma | Leukemia | MyelomaUnited States
-
MEI Pharma, Inc.Quotient ClinicalCompleted
-
Wake Forest University Health SciencesCompleted
-
Astellas Pharma Global Development, Inc.TerminatedNon-hematologic Malignancies | Pharmacokinetics of ASP9853United States
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Non-hematologic MalignanciesUnited States, Canada
-
AmgenCompletedHepatic Impairment | Solid Tumors | Hematologic MalignanciesUnited Kingdom, Netherlands, United States, France
-
Gilead SciencesCalifornia Institute for Regenerative Medicine (CIRM)CompletedAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited Kingdom
-
Barbara Ann Karmanos Cancer InstituteCompletedHematological MalignanciesUnited States
-
Genentech, Inc.CompletedHematologic Malignancies | TumorsSpain, France, United States, United Kingdom